Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.6K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.6K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

159
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
159
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

1.1K
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
1.1K
Glaucoma: Overview01:25

Glaucoma: Overview

1.7K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.7K
Genetic Lingo01:11

Genetic Lingo

84.7K
Overview
84.7K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visual field progression in varying severities of treated patients with primary angle closure glaucoma.

Scientific reports·2026
Same author

Genetic Diversity and Historical Divergence of Malays and Indigenous Populations in Peninsular Malaysia and Northern Borneo.

Annals of human genetics·2026
Same author

SYN-OCT:A synthetic dataset of ocular optical coherence tomography images from healthy and glaucoma eyes.

Scientific data·2026
Same author

Carotid Doppler imaging in glaucoma and glaucoma suspects.

Indian journal of ophthalmology·2026
Same author

AI to Identify Strain-Sensitive Regions of the Optic Nerve Head Linked to Functional Loss in Glaucoma.

Investigative ophthalmology & visual science·2026
Same author

Results of ocular biometry from a population-based study in detecting angle-closure disease in a clinical setting.

Indian journal of ophthalmology·2026
Same journal

New Guidelines for Ophthalmic Genetic Studies.

Investigative ophthalmology & visual science·2026
Same journal

Genomic Copy Number Variants Associated With Strabismus and Amblyopia in the All of Us Research Program.

Investigative ophthalmology & visual science·2026
Same journal

Xanthophyll Carotenoid Intake, Plasma Levels, and Retinal Visualization in Aging and Age-Related Macular Degeneration: ALSTAR2.

Investigative ophthalmology & visual science·2026
Same journal

Enhanced Endocytosis and Mitochondrial Stress Underlie Severe Retinitis Pigmentosa With RHO P347L Mutant.

Investigative ophthalmology & visual science·2026
Same journal

Dual-Hit Myopia Mechanism Unveiled by Multi-Omics: Opn1mw Deficiency Primed the Retina for Exaggerated Response to Environmental Defocus.

Investigative ophthalmology & visual science·2026
Same journal

Psychometric Performance of Children With Amblyopia During a Tablet-Based Adaptive Visual Acuity Assessment.

Investigative ophthalmology & visual science·2026
See all related articles

Related Experiment Video

Updated: May 3, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K

Genotype-phenotype correlation analysis for three primary angle closure glaucoma-associated genetic polymorphisms.

Xin Wei1, Monisha E Nongpiur, Mark S de Leon

  • 1Singapore Eye Research Institute, Singapore National Eye Centre, Singapore.

Investigative Ophthalmology & Visual Science
|January 30, 2014
PubMed
Summary
This summary is machine-generated.

Genetic markers for primary angle closure glaucoma (PACG) do not appear to influence disease severity or progression. This study found no significant differences in clinical features or glaucoma progression based on specific single nucleotide polymorphisms (SNPs).

Keywords:
angle closure glaucomaassociationgeneticssingle nucleotide polymorphism

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

7.7K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

7.7K

Related Experiment Videos

Last Updated: May 3, 2026

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
13:47

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis

Published on: June 3, 2018

9.3K
A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

7.7K
Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential
07:11

Assessing Early Stage Open-Angle Glaucoma in Patients by Isolated-Check Visual Evoked Potential

Published on: May 25, 2020

7.7K

Area of Science:

  • Ophthalmology
  • Genetics
  • Glaucoma Research

Background:

  • Primary angle closure glaucoma (PACG) is a significant cause of vision loss.
  • Three genetic susceptibility loci (COL11A1 rs3753841, PCMTD1-ST18 rs1015213, PLEKHA7 rs11024102) have been recently identified for PACG.
  • The phenotypic impact of these genetic loci on PACG patients remains largely unexplored.

Purpose of the Study:

  • To investigate the association between three known PACG genetic susceptibility loci and the clinical phenotype of PACG patients.
  • To determine if specific single nucleotide polymorphisms (SNPs) influence disease severity or progression in a Singaporean Chinese cohort.

Main Methods:

  • Retrospective analysis of 700 Singaporean Chinese PACG patients with available genotyping data.
  • Examination of associations between three SNPs (COL11A1 rs3753841, PCMTD1-ST18 rs1015213, PLEKHA7 rs11024102) and clinical features.
  • Subgroup analysis of patients with long-term follow-up (≥5 years) and visual field (VF) data to assess glaucoma progression and blindness rates based on genotype.

Main Results:

  • Minor allele frequencies for the studied SNPs were 36% (COL11A1), 2.1% (PCMTD1-ST18), and 41.5% (PLEKHA7).
  • No significant differences were observed in patient demographics, diagnosis type, age at diagnosis, glaucoma laterality, or need for surgery across different genotypes.
  • Genotypes did not correlate with intraocular pressure (IOP) at presentation or other clinical characteristics, including visual acuity and VF parameters.
  • No significant associations were found between the PACG susceptibility loci and VF progression or rates of blindness.

Conclusions:

  • The identified genetic susceptibility loci for PACG do not appear to be major determinants of phenotypic diversity.
  • These specific SNPs do not significantly influence disease severity or the rate of glaucoma progression in the studied population.
  • Further research may be needed to explore other genetic or environmental factors contributing to PACG phenotype variability.